
Home » Abbott Receives 483 Observations on Third-Party Supplier Issues
Abbott Receives 483 Observations on Third-Party Supplier Issues
August 2, 2011
An FDA inspection reveals that an Abbott Laboratories manufacturing site lacked adequate quality agreements for purchased products, according to a recent Form 483.
The GMP Letter
The GMP Letter
Upcoming Events
-
10Mar
-
16Mar
-
18Mar
-
23Mar
-
30Mar
-
06Apr